Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)

Completed

• Conditions: Anemia, Sickle Cell
• Interventions: Behavioral: SCDIC interventions

• Registration Number: NCT03380351
• Lead Sponsor: Washington University School of Medicine

Brief Summary

The goal of this study is to specify the interventions, implementation strategies and control conditions from the Sickle Cell Disease Implementation Consortium (SCDIC) using a mixed-methods approach to study site materials and conduct semi-structured qualitative interviews with site representatives (N=3 per site). We focused on the Emergency Department Working Group from the SCDIC working groups.

Detailed Description

The long-term goal of this line of research is to identify the most effective components of SCD interventions while also identifying effective implementation strategies informed by a systematic and rigorous work done by the members of the SCDIC consortium to improve the quality of life of people with SCD, a life-threatening hematological disorder. This study aims to collect detailed information about the planned interventions, the implementation strategies and the control conditions from each site.

Study Timeline

• Study First Submitted: 2017-11-20
• Study First Submitted QC: 2017-12-15
• Study First Posted: 2017-12-21
• Study Start: 2019-08-26
• Primary Completion: 2024-03-01
• Study Completion: 2024-03-30
• Status Verified: 2024-05
• Last Update Submitted: 2024-05-06
• Last Update Posted: 2024-05-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 17

Inclusion Criteria

• three representatives of each of the SDIC sites: the Principal Investigator, and two people nominated by the PI.

Read More

Exclusion Criteria

• none

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
SCDIC interventions	SCDIC interventions	Careful detail the intervention components and the implementation strategies (i.e., the mechanisms by which the interventions are being delivered in usual care) being developed by the consortium.

Primary Outcome Measures

Name	Time	Method
SCDIC Framework of Interventions	2 years	Detailed descriptions of the interventions being developed by the SCDIC including a) entity, or entities, targeted by the intervention; (b) functional domains targeted by the interventions; and (c) delivery system characteristics

Trial Locations

Locations (1)

Washington University in St. Louis; 🇺🇸 Saint Louis, Missouri, United States